Baltimore City school system sues drug companies over allegedly inflated price of insulin
The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...
pharmaphorum9d
NICE changes its mind on Lilly's Mounjaro for diabetes
Around 180,000 people with type 2 diabetes in the UK could be in line for treatment with Eli Lilly's Mounjaro after the drug was recommended for NHS use by cost-effectiveness overseer NICE.
Money Morning13d
Eli Lilly Faces ‘Death Cross’ Selloff: This is the Stock's Next Target Price...
The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...
Benzinga.com28d
Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'
The compounding groups filed a complaint in October 2024 alleging that removing the drug from the shortage list is based ... versions of Eli Lilly’s weight loss and diabetes drugs.
Investing17d
Eli Lilly's SWOT analysis: stock soars on diabetes drug success, eyes new markets
for both drugs, indicating strong market acceptance and potential for continued revenue growth. The success of these GLP-1 receptor agonists has positioned Eli Lilly as a leader in the diabetes ...
Yahoo Finance29d
Weight loss drugs are changing the game, Eli Lilly exec says — but many still can't get them
Earlier this year, Eli Lilly published results of a study that found that the drug behind Zepbound was found to help nearly eliminate the risk of diabetes for adults who are pre-diabetic and are ...
NBC DFW16d
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
Eli Lilly cut its 2024 revenue guidance, saying demand for its obesity and diabetes drugs had not met its lofty expectations. Eli Lilly expects about $3.5 billion in revenue for its diabetes ...